Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mTOR-based versus calcineurin inhibitor-based immunosuppression for coronary calcification progression after kidney transplantation
NL-OMON37133Active, not recruiting
- Sponsor
- Dianet
- Start
- Nov 2010
- Countries
- 1
01
Overview
Randomised, open-label trial in cardiac morbidity and arterial calcification (2 arms), sponsored by Dianet. Primary endpoint: Change in coronary artery calcification score. Started Nov 2010; status: active, not recruiting.
02
Conditions
cardiac morbidityarterial calcification
Beyond the preview
Go deeper on NL-OMON37133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37133.